| Dr Sonia A Griffith, DDS | |
|
9003 Upper Havensight Mall, Bldg. 3, Suite 307, St. Thomas, VI 00802 | |
| (340) 774-0263 | |
| (340) 774-7493 |
| Full Name | Dr Sonia A Griffith |
|---|---|
| Gender | Female |
| Speciality | Dentist - Pediatric Dentistry |
| Location | 9003 Upper Havensight Mall, St. Thomas, Virgin Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265538425 | NPI | - | NPPES |
| BG6491497 | Other | VI | DENTIST |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223P0221X | Dentist - Pediatric Dentistry | 1092 (Virgin Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sonia A Griffith, DDS D-4-n Est. Lovenlund, St. Thomas, VI 00802 Ph: (340) 775-9608 | Dr Sonia A Griffith, DDS 9003 Upper Havensight Mall, Bldg. 3, Suite 307, St. Thomas, VI 00802 Ph: (340) 774-0263 |
News Archive
Oh, the challenges of being a neuron, responsible for essential things like muscle contraction, gland secretion and sensitivity to touch, sound and light, yet constantly bombarded with signals from here, there and everywhere.
Pleural mesothelioma patients who undergo lung-sparing surgery in combination with photodynamic therapy (PDT) show superior overall survival than patient treated using the conventional therapy of extrapleural pneumonectomy (EPP) with PDT, indicates new research from the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania.
Head and neck cancer patients receiving induction chemotherapy followed by radiation to preserve their larynx have a low-risk of severe voice disability and almost half experienced no eating or swallowing problems, according to a first of its kind study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.
PROLOR Biotech, Inc., today noted the positive opinion by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency for marketing approval in Europe for ELONVA(R), a long-acting CTP-modified version of the fertility hormone FSH from Merck & Co. Merck and PROLOR are both licensees of the CTP technology from Washington University in St. Louis.
› Verified 4 days ago
Dr. Enrico Wensing, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 9053 Estate Thomas Suite 105, St. Thomas, VI 00802 Phone: 340-344-0662 | |
Gigi Caines, Dentist Medicare: Not Enrolled in Medicare Practice Location: 48 Sugar Estate, 2344 Commandant Gade #18 O.v., St. Thomas, VI 00802 Phone: 340-774-7477 Fax: 340-774-3324 |